Considering that Bim is traditionally characterized as a direct ‘activator’ of Bax/Bak, we silenced Bim expression in MCC cells by Bim shRNA followed by MLN0128 treatment (Figure 6C). The gene discussed is BAK1; the disease is Merkel cell skin cancer.